GWM
HCMT icon

Geneos Wealth Management’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Geneos Wealth Management’s Portfolio HCMT Stock Details HCMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,690
Closed -$1.03M – 2518
2025
Q4 		$1.03M Buy
+26,690
New +$1.03M 0.03% 496
2025
Q3 		– Sell
-7,381
Closed -$240K – 2787
2025
Q2 		$240K Buy
+7,381
New +$211K 0.01% 927

Other funds holding HCMT

HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
DWS
Discipline Wealth Solutions Greenville, South Carolina $950M AUM 16.22% 1-Year Est. Return
WWA
Wealth Watch Advisors Englewood, Colorado $239M AUM 21.17% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
WCM
WealthTrak Capital Management Virginia Beach, Virginia $140M AUM 17% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Geneos Wealth Management's HCMT Position: Q1 2026 in Review

Geneos Wealth Management sold out of Direxion HCM Tactical Enhanced US ETF (HCMT) in Q1 2026, closing a stake of 26,690 shares — an estimated $1.03M sold.

Geneos Wealth Management first reported a position in HCMT in Q2 2025 and held it in 2 quarters. The position peaked at $1.03M in Q4 2025. 36 funds tracked by Wall St. Rank hold HCMT as of Q1 2026.

  • Geneos Wealth Management reported no remaining Direxion HCM Tactical Enhanced US ETF position as of Q1 2026 after selling out during the quarter.
  • Geneos Wealth Management sold 26,690 Direxion HCM Tactical Enhanced US ETF shares in Q1 2026, an estimated $1.03M.
  • Geneos Wealth Management first reported a position in Direxion HCM Tactical Enhanced US ETF in Q2 2025 and held it in 2 quarters.
  • Geneos Wealth Management's Direxion HCM Tactical Enhanced US ETF position peaked at $1.03M in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.